 | • レポートコード：MRC2203A208 • 出版社/出版日：Mordor Intelligence / 2022年1月 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Site Licence | ￥962,000 (USD6,500) | ▷ お問い合わせ |
| Corporate License | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の本市場調査レポートでは、世界の臨床試験画像市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品・サービス別（トライアルデザインコンサルティングサービス、リードアナリシスサービス、運用画像サービス、画像ソフトウェア）分析、モダリティ別（磁気共鳴画像、コンピューター断層撮影、超音波、陽電子放出断層撮影、X線）分析、エンドユーザー別（製薬企業、医療機器メーカー、学術・政府研究機関、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米）分析、競争状況、市場機会・将来傾向など、以下の構成でまとめました。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の臨床試験画像市場規模：製品・サービス別（トライアルデザインコンサルティングサービス、リードアナリシスサービス、運用画像サービス、画像ソフトウェア） ・世界の臨床試験画像市場規模：モダリティ別（磁気共鳴画像、コンピューター断層撮影、超音波、陽電子放出断層撮影、X線） ・世界の臨床試験画像市場規模：エンドユーザー別（製薬企業、医療機器メーカー、学術・政府研究機関、その他） ・世界の臨床試験画像市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米） ・競争状況（Bioclinica Inc.、Biomedical Systems Corporation、Biotelemetry Inc.、…） ・市場機会・将来傾向 |
The clinical trial imaging market will grow due to the rise in the number of contract research organization, an increase in the R&D spending and growth in the pharmaceutical and biotechnological companies.
With the increasing advancements in science and technology, there has been an increasing growth of pharmaceutical companies across the globe. The rise in the number of pharmaceutical and biotechnology companies is making it imperative for the manufacturers to deliver the best possible drug or medicine to the end-user, as competition is striking the companies. This factor is contributing to the rise of clinical trials as a large number of novel drug discoveries are being done by these companies.
Thus, the rise in the number of drug discoveries is fuelling the demand for implementation of imaging technologies in clinical trials. This is positively affecting the growing number of pharmaceutical and biotechnological companies.
In addition the improvements seen in the overall regulatory framework has also affected the market growth and the acceptance of imaging technologies in clinical trials.
Key Market Trends
Computed Tomography is Expected to Witness Rapid Growth
Computed tomography is a non-invasive medical procedure that makes use of X-Rays to generate cross-sectional images of the body and provides detailed information for the treatment and examines abnormalities in children and adults.
Computed tomography (CT) segment growth is being attributed to extensive advantages CT offers such as the study of drug activity and screenings for injuries, cancer (tumors), and abnormalities inside the body. Furthermore, the increased funding and investment in the field of clinical research and clinical trials is boosting the segment growth. The large share of this segment is also attributed to the high advantages of CT in screenings for cancer (tumors), injuries.
North America is Anticipated to Dominate the Clinical Trial Imaging Market
North America is found dominating the clinical trial imaging market due to the rising prevalence of chronic diseases combined with increasing geriatric population that is poised to spur the growth of the regional market. Besides this, the advancements in healthcare infrastructure are enabling faster diagnosis and treatment of chronic diseases.
However, the US FDA and other regulatory organizations have also played a leading role in attaining accomplishments of trial registration to date and is likely to be supported in tackling such challenges in the near future. Owing to all these factors, the regional market is projected to maintain its position in the market throughout the forecast period.
Competitive Landscape
The key participants of the market studied include Bioclinica Inc, Ixico PLC, Icon PLC, Intrinsic Imaging LLC, Radiant Sage LLC and Parexel International Corporation. These major players are undertaking growth strategies such as new product launches, mergers and acquisitions to retain share and diversify product portfolio.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growth in The Pharmaceutical and Biotechnological Companies
4.2.2 Rise in Number of Contract Research Organization
4.2.3 Increase in R&D Spending
4.3 Market Restraints
4.3.1 High Implementation Barriers and Costs of Imaging Systems
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product and Service
5.1.1 Trial Design Consulting Services
5.1.2 Read Analysis Services
5.1.3 Operational Imaging Services
5.1.4 Imaging Software
5.2 By Modality
5.2.1 Magnetic Resonance Imaging
5.2.2 Computed Tomography
5.2.3 Ultrasound
5.2.4 Positron Emission Tomography
5.2.5 X-Ray
5.2.6 Echocardiography
5.2.7 Other Modalities
5.3 By End-User
5.3.1 Pharmaceutical Companies
5.3.2 Medical Device Manufacturers
5.3.3 Academic and Government Research Institutes
5.3.4 Other End-Users
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Bioclinica Inc.
6.1.2 Biomedical Systems Corporation
6.1.3 Biotelemetry Inc.
6.1.4 Cardiovascular Imaging Technologies LLC
6.1.5 Icon PLC
6.1.6 Intrinsic Imaging LLC
6.1.7 Ixico PLC
6.1.8 Parexel International Corporation
6.1.9 Radiant Sage LLC
6.1.10 Worldcare Clinical LLC
7 MARKET OPPORTUNITIES AND FUTURE TRENDS